Junwen Wang

Dr. Junwen Wang


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MNMatthew R Nelson
Matthew R Nelson
HTHannah Tipney
Hannah Tipney
JPJeffery L Painter
Jeffery L Painter
JSJudong Shen
Judong Shen
PNPaola Nicoletti
Paola Nicoletti
PSPhilippe Sanseau
Philippe Sanseau

27 May 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DHDavid J Hunter
David J Hunter
PKPeter Kraft
Peter Kraft
KJKevin B Jacobs
Kevin B Jacobs
DCDavid G Cox
David G Cox
MYMeredith Yeager
Meredith Yeager
SCStephen J Chanock
Stephen J Chanock

11 November 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
QLQing Lan
Qing Lan
CHChao A Hsiung
Chao A Hsiung
Keitaro MatsuoKeitaro Matsuo
Keitaro Matsuo
YHYun-Chul Hong
Yun-Chul Hong
ASAdeline Seow
Adeline Seow
NRNathaniel Rothman
Nathaniel Rothman

19 September 2006 in Circulation
Verified
Journal Article
Closed access
PDF file
SHSridhar Hannenhalli
Sridhar Hannenhalli
MPMary E. Putt
Mary E. Putt
JGJoan M. Gilmore
Joan M. Gilmore
JWJunwen Wang
Junwen Wang
MPMichael S. Parmacek
Michael S. Parmacek
TCThomas P. Cappola
Thomas P. Cappola
Background— Specific transcription factors (TFs) modulate cardiac gene expression in murine models of heart failure, but their relevance in human subjects remains untested. We developed and applied a computational approach called transcriptional genomics to test the hypothesis that a discrete set of cardiac TFs is associated with human heart failure. Methods and Results— RNA isolates from failing (n=196) and nonfailing (n=16) human hearts were hybridized with Affymetrix HU133A arrays, and differentially expressed heart failure genes were determined. TF binding sites overrepresented in the −5-kb promoter sequences of these heart failure genes were then determined with the use of public genome sequence databases. Binding sites for TFs identified in murine heart failure models (MEF2, NKX, NF-AT, and GATA) were significantly overrepresented in promoters of human heart failure genes ( P <0.002; false discovery rate 2% to 4%). In addition, binding sites for FOX TFs showed substantial overrepresentation in both advanced human and early murine heart failure ( P <0.002 and false discovery rate <4% for each). A role for FOX TFs was supported further by expression of FOXC1, C2, P1, P4, and O1A in failing human cardiac myocytes at levels similar to established hypertrophic TFs and by abundant FOXP1 protein in failing human cardiac myocyte nuclei. Conclusions— Our results provide the first evidence that specific TFs identified in murine models (MEF2, NKX, NFAT, and GATA) are associated with human heart failure. Moreover, these data implicate specific members of the FOX family of TFs (FOXC1, C2, P1, P4, and O1A) not previously suggested in heart failure pathogenesis. These findings provide a crucial link between animal models and human disease and suggest a specific role for FOX signaling in modulating the hypertrophic response of the heart to stress in humans.

1 December 2011 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MLMulin Jun Li
Mulin Jun Li
PWPanwen Wang
Panwen Wang
XLXiaorong Liu
Xiaorong Liu
ELEe Lyn Lim
Ee Lyn Lim
ZWZhangyong Wang
Zhangyong Wang
JWJunwen Wang
Junwen Wang
Recent advances in genome-wide association studies (GWAS) have enabled us to identify thousands of genetic variants (GVs) that are associated with human diseases. As next-generation sequencing technologies become less expensive, more GVs will be discovered in the near future. Existing databases, such as NHGRI GWAS Catalog, collect GVs with only genome-wide level significance. However, many true disease susceptibility loci have relatively moderate P values and are not included in these databases. We have developed GWASdb that contains 20 times more data than the GWAS Catalog and includes less significant GVs (P < 1.0 × 10−3) manually curated from the literature. In addition, GWASdb provides comprehensive functional annotations for each GV, including genomic mapping information, regulatory effects (transcription factor binding sites, microRNA target sites and splicing sites), amino acid substitutions, evolution, gene expression and disease associations. Furthermore, GWASdb classifies these GVs according to diseases using Disease-Ontology Lite and Human Phenotype Ontology. It can conduct pathway enrichment and PPI network association analysis for these diseases. GWASdb provides an intuitive, multifunctional database for biologists and clinicians to explore GVs and their functional inferences. It is freely available at http://jjwanglab.org/gwasdb and will be updated frequently.

21 February 2018 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
PDF file
SYShun H Yip
Shun H Yip
PSPak Chung Sham
Pak Chung Sham
JWJunwen Wang
Junwen Wang
Traditional RNA sequencing (RNA-seq) allows the detection of gene expression variations between two or more cell populations through differentially expressed gene (DEG) analysis. However, genes that contribute to cell-to-cell differences are not discoverable with RNA-seq because RNA-seq samples are obtained from a mixture of cells. Single-cell RNA-seq (scRNA-seq) allows the detection of gene expression in each cell. With scRNA-seq, highly variable gene (HVG) discovery allows the detection of genes that contribute strongly to cell-to-cell variation within a homogeneous cell population, such as a population of embryonic stem cells. This analysis is implemented in many software packages. In this study, we compare seven HVG methods from six software packages, including BASiCS, Brennecke, scLVM, scran, scVEGs and Seurat. Our results demonstrate that reproducibility in HVG analysis requires a larger sample size than DEG analysis. Discrepancies between methods and potential issues in these tools are discussed and recommendations are made.